Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0262-2018Class II

Rezum System, Vapor BPH Ablation System, Model Number D2201-003. NxThera Inc. 7351 Kirkwood Lane Suite 138...

Nxthera, Inc. / initiated 2017-07-28 / Terminated / root cause: manufacturing process

NXTHERA began a recall of Rezum System, Vapor BPH Ablation System, Model Number D2201-003. NxThera Inc. 7351 Kirkwood Lane Suite 138 Maple Grove, MN 55369 USA. Intended to relieve... on . FDA classified it as Class II and gives the reason as "Needle Bond may not be able to withstand the tension force applied when the shaped needle is deployed into and retracted from prostate tissue to deliver treatments". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0262-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Nxthera, Inc.
Product
Rezum System, Vapor BPH Ablation System, Model Number D2201-003. NxThera Inc. 7351 Kirkwood Lane Suite 138 Maple Grove, MN 55369 USA. Intended to relieve symptoms, obstructions, and reduce prostate tissue associated with benign prostatic hyperplasia (BPH). It is indicated for men greater or equal to 50 years of age with a prostate volume greater than or equal to 30cm3 and less than or equal to 80cm3. The Rezum System is also indicated for treatment of prostates with hyperplasia of the central zone and/or a median lobe.
Product code
KNS Unit, Electrosurgical, Endoscopic (With Or Without Accessories)
Reason for recall
Needle Bond may not be able to withstand the tension force applied when the shaped needle is deployed into and retracted from prostate tissue to deliver treatments.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Customers were notified initially by sales representatives on or about July 18, 2017. Any affected devices were to be returned to NxThera. Additionally, a formal recall letter was mailed to customers on approximately July 28, 2017. NxThera's telephone contact information and FEDEX number will be provided on the verification form. For further questions, please call (763) 515-2084..
Quantity in commerce
113 units total
Distribution
USA Distribution to the states of : AL, AZ, CA, CO, FL, GA, IL, MA, MI, MN, MO, NE, NJ, NY, OH, PA, TN, UT, WA.
Product codes and lots
UDI 08855757006010. Lot Number of Outside Cases (Pack Lot) 2017020920 with Lot Number of Inside Boxes (Product Lot) 2017011612 and Exp Date 2018-01-31: Lot Number of Outside Cases (Pack Lot) 2017030286 with Lot Number of Inside Boxees (Product Lot) 2017011187 and Exp Date 2018-01-31.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0262-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0262-2018Class IITerminatedVoluntary: Firm initiated